miR-223: An inflammatory oncomiR enters the cardiovascular field
Autor: | Fatiha Taïbi, Metzinger-Le Meuth, Laurent Metzinger, Ziad A. Massy |
---|---|
Rok vydání: | 2014 |
Předmět: |
Cellular differentiation
Cell Inflammation Biology Bioinformatics medicine.disease_cause Vascular disease mir-223 Neoplasms microRNA medicine Animals Humans Molecular Biology Cancer RNA MicroRNA Cell Differentiation Oncomir miR-223 Hematopoiesis MicroRNAs medicine.anatomical_structure Cardiovascular Diseases Immunology Muscle Molecular Medicine medicine.symptom Carcinogenesis |
Zdroj: | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842:1001-1009 |
ISSN: | 0925-4439 |
Popis: | MicroRNAs (miRNAs) are small, noncoding RNAs of 18–22 nucleotides in length that regulate post-transcriptional expression by base-pairing with target mRNAs. It is now clearly established that miRNAs are involved in most of the cell's physiopathological processes (including carcinogenesis and metabolic disorders). This review focuses on miR-223, which was first described as a modulator of hematopoietic lineage differentiation. We outline the role of miR-223 deregulation in several types of cancers and highlight its inclusion in a newly identified and fast-growing family of miRNAs called oncomiRs. We then look at miR-223's emerging role in inflammatory and metabolic disorders, with a particular focus on muscle diseases, type II diabetes, atherosclerosis and vascular calcification. miR-223 is one of the growing number of RNA biomarkers of various human metabolic diseases and is thus of special interest to both researchers and clinicians in the cardiovascular field. |
Databáze: | OpenAIRE |
Externí odkaz: |